Sanofi Lunsekimig Shows Strong Phase 2 Results in Asthma
Paris, France, April 7, 2026 Phase 2 Success Across Respiratory Indications In a major advancement for respiratory disease therapeutics,...
biomaterials
Advertisement
Renovare Therapeutics Launches with $33.5M ARPA-H Support
Boulder, Colorado, USA, April 6, 2026 $33.5M ARPA-H Funding Accelerates Regenerative Pipeline In a major boost to regenerative medicine...
FDA Clears Collagen Scaffold Device for Wound Care
ROSWELL, Ga., Feb. 12, 2026 — StimLabs announced that the U.S. Food and Drug Administration has granted 510(k) clearance...
Regentis Expands Phase III GelrinC Trial Across U.S. Sites
HERZLIYA, Israel, January 29, 2026 — Regentis Biomaterials Ltd. announced a significant expansion of its U.S. clinical site network...
Zimmer Biomet Earns FDA Breakthrough Status for Iodine-Treated Hip Implant
Warsaw, USA, October 28, 2025 — Zimmer Biomet Holdings, Inc. announced that the FDA has granted Breakthrough Device Designation...
Advertisement
